Author

Paul N. Clarkson

Observed names: Clarkson, Paul, Paul Clarkson

Institution: AstraZeneca (United Kingdom)

Observed institution: AstraZeneca (United Kingdom)

OpenAlex ID: A5010341139

Selective Antagonism of the NPY Y5 Receptor Does Not Have a Major Effect on Feeding in Rats

2002 · Andrew V. Turnbull, Laraine Ellershaw, et al. · Diabetes · 73

Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy

2017 · William McCoull, Andrew Bailey, et al. · Journal of Medicinal Chemistry · 35

Association of Polymorphisms in GPR10, the Gene Encoding the Prolactin-Releasing Peptide Receptor With Blood Pressure, but not Obesity, in a U.K. Caucasian Population

2003 · Sumit Bhattacharyya, Jian’an Luan, et al. · Diabetes · 34

Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase

2018 · Eilidh K. Leitch, Nagarajan Elumalai, et al. · Chemical Science · 26

Characterization of a naturally-occurring polymorphism in the UHR-1 gene encoding the putative rat prolactin-releasing peptide receptor

2005 · Kate L.J. Ellacott, Emma L. Donald, et al. · Peptides · 19

Characterization of the Kinetic Mechanism of Human Protein Arginine Methyltransferase 5

2020 · Alice R. Eddershaw, Christopher J. Stubbs, et al. · Biochemistry · 12

Dissecting the Kinetic Mechanism of Human Lysine Methyltransferase 2D and Its Interactions with the WRAD2 Complex

2022 · Lucy V. Edwardes, Sarah J. Caswell, et al. · Biochemistry · 3

CCDC 1530875: Experimental Crystal Structure Determination

2017 · McCoull, William, Bailey, Andrew, et al. · The Cambridge Structural Database

Works count: 8

Citation count: 202

H-index: 6

I10-index: 6